Skip to content

    Recently Viewed

      Listening...

      Home / Media Center / Press releases / Financial /
      Johnson & Johnson to Participate in the Goldman Sachs 39th Annual Global Healthcare Conference

      Johnson & Johnson to Participate in the Goldman Sachs 39th Annual Global Healthcare Conference

      Share Article
      share to

      New Brunswick, NJ (May 29, 2018) -- Johnson & Johnson (NYSE: JNJ) will participate in the Goldman Sachs 39th Annual Global Healthcare Conference on Tuesday, June 12, at the Terranea Resort in Rancho Palos Verdes, California. Tom Cavanaugh, President, Oncology, Janssen Pharmaceuticals and Scott White, President, Immunology will represent the Company in a session scheduled at 9:20 a.m. (Pacific Time).

      This webcast will be available to investors and other interested parties by accessing the Johnson & Johnson website at www.investor.jnj.com.

      A webcast and podcast replay will be available approximately two hours after the live webcast.

      Press Contacts:
      Ernie Knewitz
      (732) 524-6623
      (917) 697-2318 (M)

      Cristal Downing
      (732) 524-3283
      (908) 616-8833 (M)

      Investor Contacts:
      Joseph J. Wolk
      (732) 524-1142

      Lesley Fishman
      (732) 524-3922

      You are now leaving jnj.com. The site you’re being redirected to is a branded pharmaceutical website. Please click below to continue to that site.